The release of the latest documents from the national collection distribution enterprises is equally great

the whole country, Shanghai issued a supplementary documentOn January 20, Shanghai Sunshine Pharmaceutical Purchasing Network released the "National Drug Centralized Purchase Shanghai Regional Supplemental Document (GY-YD2021-1)", which provides detailed requirements for enterprise declaration, drug distribution, quality testing, tri-party agreement, payment of goods, and use of selected drugs in Shanghai.Among them, there are a few points worth focusing on.1, enterprise declarationthis centralized procurement and supply of drugs should be clinically commonly used packaging, to encourage the simultaneous provision of drugs to meet the commonly used chronic diseases of more than 2 weeks of dosing packaging.2. Drug distributiona selected drug can only entrust a drug distribution enterprise to be responsible for distribution, designated distribution enterprises should meet the following conditions:(1) designated distribution enterprises in 2020 distribution of drugs covering all districts of the city;(2) designated distribution enterprises with 24 hours to the city's health insurance fixed-point medical institutions to distribute the ability and conditions of selected drugs.Drug distribution enterprises that are responsible for distribution are not allowed to purchase the selected drugs through a third party. If it is unable to perform the above-mentioned obligations, it shall be disqualified from distribution upon confirmation and shall be punished in accordance with the provisions.3, quality testingIn order to ensure that the quality of the selected drugs before and after the selection is stable and consistent, the selected enterprises must accept the work organizations using near-infrared spectroscopy modeling and other testing methods for the supply of each batch of selected drugs for testing. The declaring enterprise must undergo sampling of the selected drugs at least twice a year and, if necessary, flight inspection.4. Payment settlementWithin 5 working days after signing the "Tri-Party Agreement on the Purchase and Sale of Drugs in The Centralized Purchase of Drugs", the work organization shall pay 50% of the total purchase price to the designated distribution enterprise;From the above points, we can find that the national drug collection in addition to directly related to the selected enterprises, medical institutions, and distribution enterprises are also very relevant, and the distribution enterprises also put forward higher requirements.

distribution companies, the pressure is equallyNational collection, is the current pharmaceutical industry every year must experience the hot spot, affecting the hearts of tens of millions of medical people. And price reduction, is a very important key word of national collection.   From the 4 plus 7, 4 plus 7 expansion, the second batch, the third batch of national collection of price reduction range, ? This keyword, for pharmaceutical companies, distribution enterprises, are so heavy.   According to the procurement documents collected by the state, the declared price must include taxes, distribution fees, etc., the actual supply price, that is, the price of the actual supply of medical institutions, this price includes all taxes and fees and distribution fees.   So, how much will the distribution fee be for the selected varieties in the collection? It is understood that the general distribution company distribution of drugs will have 5-8 points of distribution fees, according to the national collection prices, even if the distribution volume compared to the past significantly increased, but the distributor from which to earn a very small profit. With the expansion of the range of national belt procurement varieties, the distribution company will also bring great impact. In the future, the polarization between small business and big business will become more and more obvious.   Previously, the head of the joint collection office to the media to introduce the national collection will achieve four effects, including the transformation and upgrading of the pharmaceutical industry.   Promote the upgrading of pharmaceutical enterprise structure and product structure by setting quality standards and volume procurement, standardize circulation order and purify industry ecology through volume price linkage, guaranteed use and timely repayment, promote the scale, intensive and modernization of pharmaceutical distribution enterprises through regional linkage, and allow fair competition between generic and original research drugs through consistent evaluation, and promote consistent evaluation.   And let's look at the distribution rights of the Shanghai area collected by the previous batch of countries, which are basically divided mainly by the drug and the state control.   Some analysts said that from the point of view of national collection, not only shuffle drug manufacturers, in reducing drug prices at the same time, but also to drug distribution enterprises put forward higher requirements. In the future, with the expansion of the range of national collection varieties, large distribution enterprises will also be out of this competition, especially in Shanghai, such as the mode can only entrust a distribution enterprise, will greatly enhance the concentration of the industry, the era of strong Hengqiang has come. (Cypress Blue)